×
0 0.0153846153846154 0.0307692307692308 0.0307692307692308 0.0615384615384615 0.0270769230769232 0.0307692307692308 0.0153846153846154
Stockreport

BRIEF-Sage Therapeutics reports top-line results from Phase 3 STATUS trial of brexanolone [Reuters]

SAGE THERAPEUTICS (SAGE)  More Company Research Source: Reuters
Last sage therapeutics earnings: 5/3 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sagerx.com/investor-relations
PDF BRIEF-Sage Therapeutics reports top-line results from Phase 3 STATUS trial of brexanolone | Reuters Reuters Staff 1 Min Read Sept 12 (Reuters) - Sage Therapeutics Inc * Sage Therapeutics reports top-line results from Phase 3 STATUS trial of brexanolone in super-refractory status epilepticus * Sage Therapeutics Inc - ?study did not meet primary endpoint * Sage Therapeutics Inc - ?secondary endpoint results were consistent with primary endpoint in study * Sage Therapeutics Inc - ?rate of death was similar in brexanolone and placebo groups in study * Sage Therapeutics Inc - ?rate of adverse events leading to discontinuation of study drug was similar in brexanolone and placebo groups and was low overall * Sage Therapeutics Inc - ?serious adverse events were similar between two treatment groups in trial * Sage Therapeutics - about 37 percent of patients treated with open-label brexanolone after end of double-blind period achieved treatment response? Source text for Eikon: Further company c [Read more]

IMPACT SNAPSHOT EVENT TIME: SAGE
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS